Wedbush’s healthcare analyst Liana Moussatos weighed in with her views on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company’s two competitors announced phase 2 results …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) received another set of praises from analysts at Wedbush in a research note released today. The research team, led by analyst …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares are up 2.46% today, as the company will present two poster presentations highlighting new subgroup analyses from the Phase 2b FLINT trial …
Wedbush’s healthcare analyst Liana Moussatos came out with her views on XOMA Corp (NASDAQ:XOMA), after the company reported its fourth-quarter results, posting revenues of $4.3/$18.
Wedbush’s healthcare analyst Liana Moussatos came out with a research note on Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), after the company reported its fourth-quarter results and provided update on its pipeline.
In a research report issued today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), with a price target of $493, following the …
In a research report issued today, Wedbush analyst Liana Moussatos maintained an Outperform rating on Omeros (NASDAQ:OMER) with a price target of $52, following …
In a research report issued today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Regulus Therapeutics (NASDAQ:RGLS) and raised the price target …
In a research report published Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target of …
In a research note issued today, Wedbush analyst Liana Moussatos (TipRanks #1) reiterated an Outperform rating on Pacira (NASDAQ:PCRX) and slightly raised her price …
